What is the recommendation for patients who have a noncardioembolic AIS while taking antiplatelet therapy?
For patients who have a noncardioembolic AIS while taking antiplatelet therapy, switching to warfarin is not indicated for secondary stroke prevention. This recommendation is classified as III: No Benefit B-NR, which means there is no benefit from switching to warfarin.